A pharmaceutical gene therapy has shown promise in treating calmodulinopathy, a rare and hard-to-treat heart arrhythmia, according to a study published Aug. 19 in Circulation. Three genes — CALM1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results